Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/95429
Title: | Emerging microfluidics-enabled platforms for osteoarthritis management : from benchtop to bedside | Authors: | Zou, Z Luo, X Chen, Z Zhang, YS Wen, C |
Issue Date: | 2022 | Source: | Theranostics, 2022, v. 12, no. 2, p. 891-909 | Abstract: | Osteoarthritis (OA) is a prevalent debilitating age-related joint degenerative disease. It is a leading cause of pain and functional disability in older adults. Unfortunately, there is no cure for OA once the damage is established. Therefore, it promotes an urgent need for early detection and intervention of OA. Theranostics, combining therapy and diagnosis, emerges as a promising approach for OA management. However, OA theranostics is still in its infancy. Three fundamental needs have to be firstly fulfilled: i) a reliable OA model for disease pathogenesis investigation and drug screening, ii) an effective and precise diagnostic platform, and iii) an advanced fabrication approach for drug delivery and therapy. Meanwhile, microfluidics emerges as a versatile technology to address each of the needs and eventually boost the development of OA theranostics. Therefore, this review focuses on the applications of microfluidics, from benchtop to bedside, for OA modelling and drug screening, early diagnosis, and clinical therapy. We first introduce the basic pathophysiology of OA and point out the major unfilled research gaps in current OA management including lack of disease modelling and drug screening platforms, early diagnostic modalities and disease-modifying drugs and delivery approaches. Accordingly, we then summarize the state-of-the-art microfluidics technology for OA management from in vitro modelling and diagnosis to therapy. Given the existing promising results, we further discuss the future development of microfluidic platforms towards clinical translation at the crossroad of engineering and biomedicine. | Keywords: | Biosensor Intra-articular injection Microfluidics Organ-on-a-chip Osteoarthritis |
Publisher: | Ivyspring International Publisher | Journal: | Theranostics | EISSN: | 1838-7640 | DOI: | 10.7150/thno.62685 | Rights: | © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. The following publication Zou Z, Luo X, Chen Z, Zhang YS, Wen C. Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside. Theranostics 2022; 12(2):891-909 is available at https://doi.org/10.7150/thno.62685. |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Zou_Emerging_microfluidics-enabled_platforms.pdf | 1.32 MB | Adobe PDF | View/Open |
Page views
76
Last Week
0
0
Last month
Citations as of Oct 13, 2024
Downloads
54
Citations as of Oct 13, 2024
SCOPUSTM
Citations
15
Citations as of Oct 17, 2024
WEB OF SCIENCETM
Citations
13
Citations as of Oct 17, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.